Oxford vaccine gives good immune responses in elderly, trial chief says

over 4 years in nationalpost

LONDON — The COVID-19 vaccine developed by Oxford University and AstraZeneca gives good immune responses in older people, even if there is a lack of data about its exact efficacy, Oxford’s vaccine trial chief Andrew Pollard said on Wednesday. Asked about a reported comment from French President Emmanuel Macron that the vaccine is “quasi-ineffective” among […]

Mentioned in this news
Share it on